SlideShare a Scribd company logo
• Cardiogenic shock — Cardiogenic shock results from pump failure,
manifested physiologically as decreased systolic function and
depressed cardiac output .
• Cardiogenic shock is uncommon among children as compared
with adults, among whom ischemic heart disease is the major
cause.
• Cardiac causes may result from inadequate contractility or
excessively fast or slow rhythms:
21/4/2022 1
Cardiogenic Shock
Etiology
• Primary myocardial injury,
• Arrhythmias,
• Cardiomyopathy,
• Myocarditis,
• Congenital heart disease with heart failure, before or after
surgery, including heart transplantation
• Sepsis,
• Poisoning.
21/4/2022 2
• Ventricular fibrillation and pulseless ventricular
tachycardia abolish cardiac output, while diminished
ventricular filling time.
• Prolonged unrecognized supraventricular tachycardia .
• Bradyarrhythmias and complete heart block can result
in shock caused by chronotropic insufficiency.
21/4/2022 3
Arrhythmias
Blunt cardiac injury
Myocardial contusion
Traumatic aneurysm
Traumatic septal defect
Chamber rupture
Valvular rupture
21/4/2022 4
• Drug toxicity : Beta blockers, Barbiturates, Chemotherapeutic agents,
Calcium channel blockers
• Metabolic derangements : Acidosis,Hyperkalemia ,Hypocalcemia
• Hypothermia
• Hypoxic or anoxic/ischemic injury
21/4/2022 5
Others ....
History
 Cardiogenic shock – History of heart disease , history
of palpitations, signs of heart failure.
 Infant : poor feeding, poor appetite and can quickly
progress to lethargy ,
Older child : fatigue ,difficulty of breathing or chest
pain , as shock progress may experience syncope .
21/4/2022 6
The presenting signs.
• Tachypnea, Tachycardia,
• Cool extremities, delayed capillary filling time,
• Poor peripheral and/or central pulses,
• Declining mental status, coma
• Decreased urine output,
• Raised JVP ,crackles, hepatomegally,
21/4/2022 7
• Mortality exceeds 50% so focus on :
• Rapid diagnosis,
• Restoration of coronary blood flow through early revascularization,
• Complication management, and
• Maintenance of end-organ homeostasis.
21/4/2022 8
Management
Management
• Initial resuscitation
 stabilizing the airway ,breathing, circulation with
establishment of vascular access
 continues monitoring of vital signs, pulse oximetry
saturation
 chest compression indicated for bradicardia with
poor perfusion
21/4/2022 9
In uncompensated cardiogenic shock
NS bolus 5-10ml /kg over 10 to 20 mins
Dopamine 10mcg/kg/min and/or Doubutamine 10-
15mcg/kg/min infusion.
 Mechanical ventilation if patient in respiratory
distress or critically ill.
21/4/2022 10
 In compensated cardiogenic shock
Frusamide infusion 0.05-0.1mg/kg/h
Add milirnon 0.1 -1mcg/kg/min
Increased afterload state
Chx by normal HR, good central pulse, weak peripheral
pulse, cold periphery, BP normal to high, hyperlactemia
Increase infusion rate of milirnon.
21/4/2022 11
• After milirnon infusion : tachycardia, good pulse,
warm periphery, decrease UOP, slightly low BP and
hyperlactemia consider hypovlumia and administer 5-
10ml/kg fluid bolus
• When optimal cardiac out put is achieved: good
normal pulse, warm extremity, good UOP, normal BP
and normal lactate maintain the same inotropic
support.
21/4/2022 12
Treatment of Precipitating factor
Arrhythmia,
Drug toxicity ,
Underlying infection,
Anemia,
Metabolic derangements,
21/4/2022 13
Distributive shock
• Refers to a condition in which systemic vascular
resistance is initially decreased.
• It may occur as the result of sepsis, anaphylaxis, or
neurologic injury.
• Associated with increased capillary permeability with
loss of plasma from the intravascular space into the
tissues.
• Significant decreases in both preload and after load
21/4/2022 14
Anaphylacyic shock
 Cutaneous : sudden onset of generalized urticaria,
angioedema, flushing, pruritus.
• However, 10 to 20% of patients have no skin findings.
 Respiratory : Stridor and wheezing
 Cardiovascular : Decreased Blood Pressure
21/4/2022 15
• Air way management
 Place patient in recumbent position, if tolerated, and elevate lower
extremities.
 Immediate intubation if evidence of impending airway obstruction from
angioedema.
 Oxygen: Give 8 to 10 L/minute via facemask or up to 100% oxygen, as
needed.
21/4/2022 16
Management
• Fluid managment
 Normal saline rapid bolus: Rapid infusion of 20 mL/kg. Re-evaluate and repeat
fluid boluses (20 mL/kg), repeat as needed.
• Epinephrine
 IM epinephrine (1 mg/mL preparation): 0.01 mg/kg should be injected
intramuscularly in the mid-outer thigh. the maximum is 0.5 mg per dose. If
there is no response or inadequate, it can be repeated in 5 to 15 minutes
21/4/2022 17
Treatment of Refractory symptoms:
• Epinephrine infusion: In patients with inadequate response to IM
epinephrine and IV saline, give epinephrine continuous infusion at 0.1 to
1 mcg/kg/minute, titrated to effect.
• Vasopressors: Patients may require large amounts of IV crystalloid to
maintain blood pressure and may require a second vasopressor
• Albuterol: For bronchospasm resistant to IM epinephrine, give albuterol
0.15 mg/kg (minimum dose: 2.5 mg) in 3 mL saline via nebulizer. Repeat,
as needed.
21/4/2022 18
Obstructive shock
• Describes physical obstruction of systemic blood flow
from the heart which causes abrupt impairment of
cardiac output.
• The acute presentation may quickly progress to
cardiac arrest.
• Children with severe respiratory distress and signs of
circulatory compromise may have obstructive shock.
21/4/2022 19
Etiology
• Tension pneumothorax,
• Cardiac tamponade,
• Hemothorax,
• Pulmonary embolism,
• Ductal-dependent congenital heart defects
21/4/2022 20
Management
 Adressing the primary insult
 pericardiocentesis for pericardial effusion
 pleurocentesis for pneumothorax
 Thrombectomy/thrombolysis for pulmonary embolism
 prostaglandin infusion for ductus-dependent cardiac lesions.
 Fluid resuscitation
 There is often a “last-drop” phenomenon associated with some
obstructive lesions.
21/4/2022 21
Shock in SAM patients
• Sunken eyes, lethargy, and tenting of skin may occur from malnutrition
alone and can cause clinicians to overestimate the degree of
dehydration.
Diagnosis of Shock
 lethargic or unconscious and cold hands
• Plus either:
 slow capillary refill (longer than 3 sec) or weak fast pulse.
21/4/2022 22
Management
 Give oxygen
 Give sterile 10% glucose (5 mL/kg) by IV
 Give IV fluid at 15 mL/kg over 1 hr, if improvement isues repeat IV 15
mL/kg for 1 more hr.
 Switch to oral or nasogastric rehydration with ReSoMal, 5-10 mL/kg
alternate hr with F-75 until fully rehydrated.
21/4/2022 23
Refractory cases
If there are no signs of improvement : ? Septic
Give maintenance fluid IV (4 mL/kg/hr) while waiting for
blood
Transfuse 10 mL/kg fresh whole blood slowly over 3 hr. If
signs of heart failure, give 5-7 mL/kg packed cells .
Give furosemide 1 mL/kg IV at the start of the transfusion
21/4/2022 24
PITFALLS
 Failure to recognize nonspecific signs of compensated shock
 Inadequate monitoring of response to treatment
 Inappropriate volume for fluid resuscitation
 Failure to reconsider possible causes of shock for children who are getting
worse.
 Failure to recognize and treat obstructive shock.
21/4/2022 25
21/4/2022 26
 A 5 year old child is brought to the ED after sustained
blunt chest trauma on P/E he is conscious, no bleeding
from any site ,V/S BP is 60/40, PR =80 bts/min ,RR=45
brths/min , T=36.6 c , SPO2 70%
Capillary refill is <2sec ,
Resp : IC / SC Retraction, Hyperesonant left chest ,
Tracheal shift to the right .
Cvs : Distended neck vein
How do you manage ?
21/4/2022 27
Clinical Trial
• However, evidence suggests that the WHO
recommendations for fluid resuscitation in severely
malnourished may be too restrictive. For example, in
an observational study of fluid resuscitation in 149
severely malnourished children with cholera and
severe dehydration, infusion of approximately 20
mL/kg per hour of an isotonic saline solution over four
to six hours was not associated with heart failure in
any patient, and all patients survived .
21/4/2022 28
Reference
• Up-to-date
• Nelson 2021 edition
• Pediatrics Advanced life support guideline
• SAM guideline 2020 , 3rd edition
21/4/2022
29

More Related Content

Similar to presentation - Copy.pptx

Management of patients with complications from heart diseases
Management of patients with complications from heart diseasesManagement of patients with complications from heart diseases
Management of patients with complications from heart diseases
Kathy Clavano
 
SHOCK
SHOCKSHOCK
Pals 2017 part 2
Pals 2017  part 2Pals 2017  part 2
Pals 2017 part 2
Sayed Ahmed
 
ASPHYXIA.ppt
ASPHYXIA.pptASPHYXIA.ppt
ASPHYXIA.ppt
ChristopherChewe4
 
Cardiovascular emergencies
Cardiovascular emergenciesCardiovascular emergencies
Cardiovascular emergencies
Ramachandra Barik
 
APPROACH TO CHILD WIYH SHOCK DJ.pptx
APPROACH TO CHILD WIYH SHOCK DJ.pptxAPPROACH TO CHILD WIYH SHOCK DJ.pptx
APPROACH TO CHILD WIYH SHOCK DJ.pptx
Dawit Solomon
 
Neonatal emergencies
Neonatal emergenciesNeonatal emergencies
Neonatal emergencies
Natangwe Tangi
 
Drugs not in common use in cardiac ER
Drugs not in common use in cardiac ERDrugs not in common use in cardiac ER
Drugs not in common use in cardiac ER
Amir Mahmoud
 
Neonatal emergencies guidelines
Neonatal emergencies guidelinesNeonatal emergencies guidelines
Neonatal emergencies guidelines
Sayed Ahmed
 
CONGESTIVE HEART FAILURE.pptx
CONGESTIVE HEART FAILURE.pptxCONGESTIVE HEART FAILURE.pptx
CONGESTIVE HEART FAILURE.pptx
Anjana KS
 
ADVERSE EFFECTS OF CONTRAST AGENTS ppt.pptx
ADVERSE EFFECTS OF CONTRAST AGENTS ppt.pptxADVERSE EFFECTS OF CONTRAST AGENTS ppt.pptx
ADVERSE EFFECTS OF CONTRAST AGENTS ppt.pptx
rohanjohnjacob
 
ADVERSE EFFECTS OF CONTRAST AGENTS ppt.pptx
ADVERSE EFFECTS OF CONTRAST AGENTS ppt.pptxADVERSE EFFECTS OF CONTRAST AGENTS ppt.pptx
ADVERSE EFFECTS OF CONTRAST AGENTS ppt.pptx
rohanjohnjacob
 
neonatalemergenciesguidelines-181113101542 (1).pdf
neonatalemergenciesguidelines-181113101542 (1).pdfneonatalemergenciesguidelines-181113101542 (1).pdf
neonatalemergenciesguidelines-181113101542 (1).pdf
YasserMojtba
 
Seminar on shock
Seminar on shockSeminar on shock
Seminar on shock
Dr. Habibur Rahim
 
Pediatric_Shock.pptx
Pediatric_Shock.pptxPediatric_Shock.pptx
Pediatric_Shock.pptx
AlfredBorden5
 
Medical and Surgical Nursing Review Bullets
Medical and Surgical Nursing Review BulletsMedical and Surgical Nursing Review Bullets
Medical and Surgical Nursing Review Bullets
MarkFredderickAbejo
 
Sepsis
SepsisSepsis
drug book in critical care nursing .docx
drug book in critical care nursing .docxdrug book in critical care nursing .docx
drug book in critical care nursing .docx
PGIMS Rohtak
 
stroke presentation that covers every aspect of Focal neurological deficit
stroke presentation that covers every aspect of Focal neurological deficitstroke presentation that covers every aspect of Focal neurological deficit
stroke presentation that covers every aspect of Focal neurological deficit
Nausheen57
 
Patho pharm cardio
Patho pharm cardioPatho pharm cardio
Patho pharm cardio
cecegator
 

Similar to presentation - Copy.pptx (20)

Management of patients with complications from heart diseases
Management of patients with complications from heart diseasesManagement of patients with complications from heart diseases
Management of patients with complications from heart diseases
 
SHOCK
SHOCKSHOCK
SHOCK
 
Pals 2017 part 2
Pals 2017  part 2Pals 2017  part 2
Pals 2017 part 2
 
ASPHYXIA.ppt
ASPHYXIA.pptASPHYXIA.ppt
ASPHYXIA.ppt
 
Cardiovascular emergencies
Cardiovascular emergenciesCardiovascular emergencies
Cardiovascular emergencies
 
APPROACH TO CHILD WIYH SHOCK DJ.pptx
APPROACH TO CHILD WIYH SHOCK DJ.pptxAPPROACH TO CHILD WIYH SHOCK DJ.pptx
APPROACH TO CHILD WIYH SHOCK DJ.pptx
 
Neonatal emergencies
Neonatal emergenciesNeonatal emergencies
Neonatal emergencies
 
Drugs not in common use in cardiac ER
Drugs not in common use in cardiac ERDrugs not in common use in cardiac ER
Drugs not in common use in cardiac ER
 
Neonatal emergencies guidelines
Neonatal emergencies guidelinesNeonatal emergencies guidelines
Neonatal emergencies guidelines
 
CONGESTIVE HEART FAILURE.pptx
CONGESTIVE HEART FAILURE.pptxCONGESTIVE HEART FAILURE.pptx
CONGESTIVE HEART FAILURE.pptx
 
ADVERSE EFFECTS OF CONTRAST AGENTS ppt.pptx
ADVERSE EFFECTS OF CONTRAST AGENTS ppt.pptxADVERSE EFFECTS OF CONTRAST AGENTS ppt.pptx
ADVERSE EFFECTS OF CONTRAST AGENTS ppt.pptx
 
ADVERSE EFFECTS OF CONTRAST AGENTS ppt.pptx
ADVERSE EFFECTS OF CONTRAST AGENTS ppt.pptxADVERSE EFFECTS OF CONTRAST AGENTS ppt.pptx
ADVERSE EFFECTS OF CONTRAST AGENTS ppt.pptx
 
neonatalemergenciesguidelines-181113101542 (1).pdf
neonatalemergenciesguidelines-181113101542 (1).pdfneonatalemergenciesguidelines-181113101542 (1).pdf
neonatalemergenciesguidelines-181113101542 (1).pdf
 
Seminar on shock
Seminar on shockSeminar on shock
Seminar on shock
 
Pediatric_Shock.pptx
Pediatric_Shock.pptxPediatric_Shock.pptx
Pediatric_Shock.pptx
 
Medical and Surgical Nursing Review Bullets
Medical and Surgical Nursing Review BulletsMedical and Surgical Nursing Review Bullets
Medical and Surgical Nursing Review Bullets
 
Sepsis
SepsisSepsis
Sepsis
 
drug book in critical care nursing .docx
drug book in critical care nursing .docxdrug book in critical care nursing .docx
drug book in critical care nursing .docx
 
stroke presentation that covers every aspect of Focal neurological deficit
stroke presentation that covers every aspect of Focal neurological deficitstroke presentation that covers every aspect of Focal neurological deficit
stroke presentation that covers every aspect of Focal neurological deficit
 
Patho pharm cardio
Patho pharm cardioPatho pharm cardio
Patho pharm cardio
 

More from hailuhenock

Concept note presentation.pptx
Concept note presentation.pptxConcept note presentation.pptx
Concept note presentation.pptx
hailuhenock
 
PIDC G Round.pptx
PIDC G Round.pptxPIDC G Round.pptx
PIDC G Round.pptx
hailuhenock
 
PIDC grand round DD.pptx
PIDC grand round DD.pptxPIDC grand round DD.pptx
PIDC grand round DD.pptx
hailuhenock
 
PIDC_grand_round_final.pptx
PIDC_grand_round_final.pptxPIDC_grand_round_final.pptx
PIDC_grand_round_final.pptx
hailuhenock
 
PEDIATRICS_SHOCK_MANAGMENT.pptx1114[1].pptx
PEDIATRICS_SHOCK_MANAGMENT.pptx1114[1].pptxPEDIATRICS_SHOCK_MANAGMENT.pptx1114[1].pptx
PEDIATRICS_SHOCK_MANAGMENT.pptx1114[1].pptx
hailuhenock
 
primary immunodeficiency HH.pptx
primary immunodeficiency HH.pptxprimary immunodeficiency HH.pptx
primary immunodeficiency HH.pptx
hailuhenock
 
Grand round GI edom.pptx
Grand round GI edom.pptxGrand round GI edom.pptx
Grand round GI edom.pptx
hailuhenock
 
Grand Round GI new.pptx
Grand Round GI new.pptxGrand Round GI new.pptx
Grand Round GI new.pptx
hailuhenock
 
presentation.pptx
presentation.pptxpresentation.pptx
presentation.pptx
hailuhenock
 

More from hailuhenock (9)

Concept note presentation.pptx
Concept note presentation.pptxConcept note presentation.pptx
Concept note presentation.pptx
 
PIDC G Round.pptx
PIDC G Round.pptxPIDC G Round.pptx
PIDC G Round.pptx
 
PIDC grand round DD.pptx
PIDC grand round DD.pptxPIDC grand round DD.pptx
PIDC grand round DD.pptx
 
PIDC_grand_round_final.pptx
PIDC_grand_round_final.pptxPIDC_grand_round_final.pptx
PIDC_grand_round_final.pptx
 
PEDIATRICS_SHOCK_MANAGMENT.pptx1114[1].pptx
PEDIATRICS_SHOCK_MANAGMENT.pptx1114[1].pptxPEDIATRICS_SHOCK_MANAGMENT.pptx1114[1].pptx
PEDIATRICS_SHOCK_MANAGMENT.pptx1114[1].pptx
 
primary immunodeficiency HH.pptx
primary immunodeficiency HH.pptxprimary immunodeficiency HH.pptx
primary immunodeficiency HH.pptx
 
Grand round GI edom.pptx
Grand round GI edom.pptxGrand round GI edom.pptx
Grand round GI edom.pptx
 
Grand Round GI new.pptx
Grand Round GI new.pptxGrand Round GI new.pptx
Grand Round GI new.pptx
 
presentation.pptx
presentation.pptxpresentation.pptx
presentation.pptx
 

Recently uploaded

Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Swastik Ayurveda
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
Dhayanithi C
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
KafrELShiekh University
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
The Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in IndiaThe Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in India
Swastik Ayurveda
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
Donc Test
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
rightmanforbloodline
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
arahmanzai5
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 

Recently uploaded (20)

Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
The Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in IndiaThe Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in India
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 

presentation - Copy.pptx

  • 1. • Cardiogenic shock — Cardiogenic shock results from pump failure, manifested physiologically as decreased systolic function and depressed cardiac output . • Cardiogenic shock is uncommon among children as compared with adults, among whom ischemic heart disease is the major cause. • Cardiac causes may result from inadequate contractility or excessively fast or slow rhythms: 21/4/2022 1 Cardiogenic Shock
  • 2. Etiology • Primary myocardial injury, • Arrhythmias, • Cardiomyopathy, • Myocarditis, • Congenital heart disease with heart failure, before or after surgery, including heart transplantation • Sepsis, • Poisoning. 21/4/2022 2
  • 3. • Ventricular fibrillation and pulseless ventricular tachycardia abolish cardiac output, while diminished ventricular filling time. • Prolonged unrecognized supraventricular tachycardia . • Bradyarrhythmias and complete heart block can result in shock caused by chronotropic insufficiency. 21/4/2022 3 Arrhythmias
  • 4. Blunt cardiac injury Myocardial contusion Traumatic aneurysm Traumatic septal defect Chamber rupture Valvular rupture 21/4/2022 4
  • 5. • Drug toxicity : Beta blockers, Barbiturates, Chemotherapeutic agents, Calcium channel blockers • Metabolic derangements : Acidosis,Hyperkalemia ,Hypocalcemia • Hypothermia • Hypoxic or anoxic/ischemic injury 21/4/2022 5 Others ....
  • 6. History  Cardiogenic shock – History of heart disease , history of palpitations, signs of heart failure.  Infant : poor feeding, poor appetite and can quickly progress to lethargy , Older child : fatigue ,difficulty of breathing or chest pain , as shock progress may experience syncope . 21/4/2022 6
  • 7. The presenting signs. • Tachypnea, Tachycardia, • Cool extremities, delayed capillary filling time, • Poor peripheral and/or central pulses, • Declining mental status, coma • Decreased urine output, • Raised JVP ,crackles, hepatomegally, 21/4/2022 7
  • 8. • Mortality exceeds 50% so focus on : • Rapid diagnosis, • Restoration of coronary blood flow through early revascularization, • Complication management, and • Maintenance of end-organ homeostasis. 21/4/2022 8 Management
  • 9. Management • Initial resuscitation  stabilizing the airway ,breathing, circulation with establishment of vascular access  continues monitoring of vital signs, pulse oximetry saturation  chest compression indicated for bradicardia with poor perfusion 21/4/2022 9
  • 10. In uncompensated cardiogenic shock NS bolus 5-10ml /kg over 10 to 20 mins Dopamine 10mcg/kg/min and/or Doubutamine 10- 15mcg/kg/min infusion.  Mechanical ventilation if patient in respiratory distress or critically ill. 21/4/2022 10
  • 11.  In compensated cardiogenic shock Frusamide infusion 0.05-0.1mg/kg/h Add milirnon 0.1 -1mcg/kg/min Increased afterload state Chx by normal HR, good central pulse, weak peripheral pulse, cold periphery, BP normal to high, hyperlactemia Increase infusion rate of milirnon. 21/4/2022 11
  • 12. • After milirnon infusion : tachycardia, good pulse, warm periphery, decrease UOP, slightly low BP and hyperlactemia consider hypovlumia and administer 5- 10ml/kg fluid bolus • When optimal cardiac out put is achieved: good normal pulse, warm extremity, good UOP, normal BP and normal lactate maintain the same inotropic support. 21/4/2022 12
  • 13. Treatment of Precipitating factor Arrhythmia, Drug toxicity , Underlying infection, Anemia, Metabolic derangements, 21/4/2022 13
  • 14. Distributive shock • Refers to a condition in which systemic vascular resistance is initially decreased. • It may occur as the result of sepsis, anaphylaxis, or neurologic injury. • Associated with increased capillary permeability with loss of plasma from the intravascular space into the tissues. • Significant decreases in both preload and after load 21/4/2022 14
  • 15. Anaphylacyic shock  Cutaneous : sudden onset of generalized urticaria, angioedema, flushing, pruritus. • However, 10 to 20% of patients have no skin findings.  Respiratory : Stridor and wheezing  Cardiovascular : Decreased Blood Pressure 21/4/2022 15
  • 16. • Air way management  Place patient in recumbent position, if tolerated, and elevate lower extremities.  Immediate intubation if evidence of impending airway obstruction from angioedema.  Oxygen: Give 8 to 10 L/minute via facemask or up to 100% oxygen, as needed. 21/4/2022 16 Management
  • 17. • Fluid managment  Normal saline rapid bolus: Rapid infusion of 20 mL/kg. Re-evaluate and repeat fluid boluses (20 mL/kg), repeat as needed. • Epinephrine  IM epinephrine (1 mg/mL preparation): 0.01 mg/kg should be injected intramuscularly in the mid-outer thigh. the maximum is 0.5 mg per dose. If there is no response or inadequate, it can be repeated in 5 to 15 minutes 21/4/2022 17
  • 18. Treatment of Refractory symptoms: • Epinephrine infusion: In patients with inadequate response to IM epinephrine and IV saline, give epinephrine continuous infusion at 0.1 to 1 mcg/kg/minute, titrated to effect. • Vasopressors: Patients may require large amounts of IV crystalloid to maintain blood pressure and may require a second vasopressor • Albuterol: For bronchospasm resistant to IM epinephrine, give albuterol 0.15 mg/kg (minimum dose: 2.5 mg) in 3 mL saline via nebulizer. Repeat, as needed. 21/4/2022 18
  • 19. Obstructive shock • Describes physical obstruction of systemic blood flow from the heart which causes abrupt impairment of cardiac output. • The acute presentation may quickly progress to cardiac arrest. • Children with severe respiratory distress and signs of circulatory compromise may have obstructive shock. 21/4/2022 19
  • 20. Etiology • Tension pneumothorax, • Cardiac tamponade, • Hemothorax, • Pulmonary embolism, • Ductal-dependent congenital heart defects 21/4/2022 20
  • 21. Management  Adressing the primary insult  pericardiocentesis for pericardial effusion  pleurocentesis for pneumothorax  Thrombectomy/thrombolysis for pulmonary embolism  prostaglandin infusion for ductus-dependent cardiac lesions.  Fluid resuscitation  There is often a “last-drop” phenomenon associated with some obstructive lesions. 21/4/2022 21
  • 22. Shock in SAM patients • Sunken eyes, lethargy, and tenting of skin may occur from malnutrition alone and can cause clinicians to overestimate the degree of dehydration. Diagnosis of Shock  lethargic or unconscious and cold hands • Plus either:  slow capillary refill (longer than 3 sec) or weak fast pulse. 21/4/2022 22
  • 23. Management  Give oxygen  Give sterile 10% glucose (5 mL/kg) by IV  Give IV fluid at 15 mL/kg over 1 hr, if improvement isues repeat IV 15 mL/kg for 1 more hr.  Switch to oral or nasogastric rehydration with ReSoMal, 5-10 mL/kg alternate hr with F-75 until fully rehydrated. 21/4/2022 23
  • 24. Refractory cases If there are no signs of improvement : ? Septic Give maintenance fluid IV (4 mL/kg/hr) while waiting for blood Transfuse 10 mL/kg fresh whole blood slowly over 3 hr. If signs of heart failure, give 5-7 mL/kg packed cells . Give furosemide 1 mL/kg IV at the start of the transfusion 21/4/2022 24
  • 25. PITFALLS  Failure to recognize nonspecific signs of compensated shock  Inadequate monitoring of response to treatment  Inappropriate volume for fluid resuscitation  Failure to reconsider possible causes of shock for children who are getting worse.  Failure to recognize and treat obstructive shock. 21/4/2022 25
  • 27.  A 5 year old child is brought to the ED after sustained blunt chest trauma on P/E he is conscious, no bleeding from any site ,V/S BP is 60/40, PR =80 bts/min ,RR=45 brths/min , T=36.6 c , SPO2 70% Capillary refill is <2sec , Resp : IC / SC Retraction, Hyperesonant left chest , Tracheal shift to the right . Cvs : Distended neck vein How do you manage ? 21/4/2022 27
  • 28. Clinical Trial • However, evidence suggests that the WHO recommendations for fluid resuscitation in severely malnourished may be too restrictive. For example, in an observational study of fluid resuscitation in 149 severely malnourished children with cholera and severe dehydration, infusion of approximately 20 mL/kg per hour of an isotonic saline solution over four to six hours was not associated with heart failure in any patient, and all patients survived . 21/4/2022 28
  • 29. Reference • Up-to-date • Nelson 2021 edition • Pediatrics Advanced life support guideline • SAM guideline 2020 , 3rd edition 21/4/2022 29

Editor's Notes

  1. Cardiomyopathies – Causes of myopathic pump failure include familial, infectious, infiltrative, and idiopathic cardiomyopathies.
  2. during ventricular tachycardia decreases preload and stroke volume substantially. (as can occur with the initial presentation for infants) can decrease cardiac output Cardiac arrhythmias (eg, supraventricular or ventricular tachycardia) should be addressed prior to fluid resuscitation
  3. caused by the combination of decreased cardiac output and compensatory peripheral vasoconstriction Additional findings include tachycardia out of proportion to fever or respiratory distress, cyanosis unresponsive to oxygen, and absent femoral pulses.
  4. Besides revascularization, inotropes and vasodilators are potent medical therapies to assist the failing heart . vasodilators dec pre load ad or after load as well as svr
  5. avoid worsening myocardial insufficiency and pulmonary edema. norepinephrine and vasopressin, should generally be avoided in patients with cardiogenic shock. Treatment with dobutamine or phosphodiesterase enzyme inhibitors can improve myocardial contractility and reduce systemic vascular resistance (afterload)
  6. Results: Literature was assessed to review the use of inotropes and vasopressors in CS. Dopamine and adrenaline were associated with increased mortality and arrhythmias. Dobutamine was associated with an improvement in cardiac output, at the determinant of causing arrhythmias. noradrenaline was associated with a lower likelihood of arrhythmias and most importantly decreased mortality in CS. literature review suggests that treatment combination of the inotrope levosimendan with the vasopressor noradrenaline may be the most effective management option in CS
  7. Thus, vasopressors are frequently employed along with fluid therapy, depending upon the underlying etiology as follows Neurogenic shock is a rare, usually transient disorder that follows acute injury to the spinal cord or central nervous system, resulting in loss of sympathetic venous tone.
  8. severe hypotension ,inadq cardiac filling
  9. such as coarctation of the aorta and hypoplastic left ventricle syndrome,
  10. There is often a “last-drop” phenomenon associated with some obstructive lesions, in that small additional amounts of intravascular volume depletion may lead to a rapid deterioration, including cardiac arrest, if the obstructive lesion is not corrected.
  11. trial of 61 children with severe malnutrition accompanied by decompensated shock in the majority of patients, administration of 30 to 40 mL/kg of crystalloid fluids over two hours failed to reverse shock in over half of patients and was accompanied by high mortality
  12. (ie, unexplained tachycardia, abnormal mental status, or poor skin perfusion)